5 Star Review

"Most helpful, steered us in the right direction for treatmen...." see more

Elaine C. - Mesothelioma Patient

5 Star Review

"Because of their guidance, I was able to navigate getting my...." see more

Deanna B. - Daughter of a Mesothelioma Patient

5 Star Review

"Hearing the news about my mother's diagnosis was heartbreaki...." see more

Danielle W. - Daughter of a Mesothelioma Patient

5 Star Review

"My son Carlos was diagnosed with this terrible and unknown d...." see more

Martha M. - Mother of a Mesothelioma Patient

5 Star Review

"Extremely communicative and helped my dad get an appointment...." see more

Sunni H. - Loved One of a Mesothelioma Patient

5 Star Review

"Danielle DiPietro was an invaluable resource for me. Her sug...." see more

Deborah C. - Spouse of a Mesothelioma Patient

5 Star Review

"I was very grateful and appreciative of Dr. Smart from The M...." see more

Kimberlin C. - Spouse of a Mesothelioma Patient

5 Star Review

"In January of 2016, my husband was diagnosed with peritoneal...." see more

Gloria R. - Spouse of a Mesothelioma Patient

Expertise:
Pleural Mesothelioma
Lung Cancer
Speciality:
Radiation Oncology
Gender:
Male
Language:
English

Primary Location

Mount Sinai Hospital

1 Gustave L. Levy Pl New York, NY 10029

Directions

Get to Know Dr. Kenneth Rosenzweig

Dr. Kenneth Rosenzweig is the chairman of Mount Sinai Hospital’s Department of Radiation Oncology. He works closely with thoracic surgeon Dr. Raja Flores and epidemiologist Dr. Emanuela Taioli in providing specialized care for each patient they see.

Together, they have pioneered treatment advances that have extended survival and improved quality of life for patients with pleural mesothelioma.

For many years, Rosenzweig has worked on the implementation and evaluation of the latest techniques, including stereotactic body radiation and intensity modulated radiation therapy. He has been a leader in the use of targeted radiation therapy in combination with chemotherapy after lung-sparing pleurectomy and decortication surgery.

Under his leadership, Mount Sinai became one of the first specialty centers to utilize the intensity modulated pleural radiation therapy procedure, known as IMPRINT, as part of a multidisciplinary approach to treating mesothelioma.

“Even if radiation isn’t the ultimate cure, it’s still a good thing if we can get patients a significant amount of quality time with minimal side effects,” Rosenzweig said. “Things are getting better.”

Rosenzweig has treated mesothelioma for more than 20 years. Before coming to Mount Sinai, he spent 13 years at nearby Memorial Sloan Kettering Cancer Center in New York City. He graduated from Yale School of Medicine and did his residency and internship at Harvard Medical School.

Specialties of Dr. Kenneth Rosenzweig

  • Pleural mesothelioma
  • Research

Dr. Kenneth Rosenzweig’s Experience and Medical Education

  • Yale School of Medicine (M.D.)
  • Harvard Medical School (Residency and internship)

Awards and Certifications

  • Board certified in radiation oncology
  • ARRO Teacher of the Year, Memorial Sloan Kettering
  • Basic Science Research Award, American Society for Therapeutic Radiation and Oncology

Publications of Dr. Kenneth Rosenzweig

  • Wallner, P.E. et al. (2020, August 26). Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of Radiopharmaceuticals. Journal of the American College of Radiology.
  • Wallner, P.E. et al. (2019, May 16). Training and Education Requirements for Authorized Users of Therapeutic Radiopharmaceuticals: Changes Under Consideration for 10CFR35.390 and Their Potential Impact. Journal of the American College of Radiology.
  • Rosenzweig, K.E. & Gomez, J.E. (2017, January). Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer. Journal of Clinical Oncology.